
ICU Medical ICUI
$ 148.85
-0.79%
Quarterly report 2025-Q3
added 11-06-2025
ICU Medical Accounts Payables 2011-2026 | ICUI
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables ICU Medical
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 148 M | 150 M | 216 M | 81.1 M | 71.9 M | 129 M | 120 M | 78.2 M | 14.6 M | 13.7 M | 11.4 M | 11.3 M | 11.3 M | 13.3 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 216 M | 11.3 M | 76.4 M |
Quarterly Accounts Payables ICU Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 172 M | 169 M | 180 M | 148 M | 169 M | 156 M | 152 M | 150 M | 149 M | 167 M | - | 216 M | 205 M | 202 M | 201 M | 81.1 M | 62 M | 69.8 M | 73 M | 71.9 M | 71.9 M | 101 M | 71.9 M | 129 M | 129 M | 129 M | 129 M | 120 M | 120 M | 120 M | 120 M | 78.2 M | 78.2 M | 78.2 M | 78.2 M | 14.6 M | 14.6 M | 14.6 M | 14.6 M | 13.7 M | 13.7 M | 13.7 M | 13.7 M | 11.4 M | 11.4 M | 11.4 M | 11.4 M | 11.3 M | 11.3 M | 11.3 M | 11.3 M | 11.3 M | 11.3 M | 11.3 M | 11.3 M | 13.3 M | 13.3 M | 13.3 M | 13.3 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 216 M | 11.3 M | 80.2 M |
Accounts Payables of other stocks in the Medical instruments industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
6.63 K | - | - | $ 810 M | ||
|
Baxter International
BAX
|
968 M | $ 20.1 | 1.85 % | $ 10.3 B | ||
|
Ekso Bionics Holdings
EKSO
|
1.55 M | $ 8.57 | 2.15 % | $ 173 M | ||
|
AtriCure
ATRC
|
25 M | $ 36.9 | -0.14 % | $ 1.73 B | ||
|
electroCore
ECOR
|
2.16 M | $ 6.6 | -7.04 % | $ 36.4 K | ||
|
Haemonetics Corporation
HAE
|
67 M | $ 66.55 | 0.88 % | $ 3.35 B | ||
|
AngioDynamics
ANGO
|
33.3 M | $ 10.3 | 3.21 % | $ 421 M | ||
|
InfuSystem Holdings
INFU
|
8.34 M | $ 8.27 | 2.73 % | $ 171 M | ||
|
The Cooper Companies
COO
|
300 M | $ 81.34 | 1.21 % | $ 16.2 B | ||
|
Harvard Bioscience
HBIO
|
5.55 M | $ 0.5 | -6.73 % | $ 21.2 M | ||
|
Glaukos Corporation
GKOS
|
13.4 M | $ 119.29 | 0.28 % | $ 5.78 B | ||
|
Repro Med Systems
KRMD
|
975 K | $ 5.39 | -1.1 % | $ 246 M | ||
|
iRhythm Technologies
IRTC
|
7.22 M | $ 154.21 | 3.5 % | $ 4.81 B | ||
|
LeMaitre Vascular
LMAT
|
1.76 M | $ 84.97 | 1.32 % | $ 1.91 B | ||
|
Masimo Corporation
MASI
|
253 M | $ 137.49 | 0.91 % | $ 7.33 B | ||
|
Intuitive Surgical
ISRG
|
193 M | $ 505.17 | -0.47 % | $ 179 B | ||
|
Merit Medical Systems
MMSI
|
68.5 M | $ 80.93 | 0.85 % | $ 4.71 B | ||
|
Microbot Medical
MBOT
|
357 K | $ 1.81 | -2.96 % | $ 18.5 M | ||
|
Nephros
NEPH
|
873 K | $ 4.35 | -0.91 % | $ 45.2 M | ||
|
Milestone Scientific
MLSS
|
780 K | $ 0.29 | -2.67 % | $ 23.1 M | ||
|
NeuroMetrix
NURO
|
363 K | - | 5.05 % | $ 9.02 M | ||
|
Envista Holdings Corporation
NVST
|
175 M | $ 23.4 | 0.13 % | $ 4.03 B | ||
|
OraSure Technologies
OSUR
|
8.17 M | $ 2.78 | -0.54 % | $ 207 M | ||
|
Pro-Dex
PDEX
|
4.61 M | $ 38.77 | -1.61 % | $ 127 M | ||
|
Predictive Oncology
POAI
|
1.14 M | - | - | $ 31.1 M | ||
|
Pulse Biosciences
PLSE
|
1.84 M | $ 13.76 | 0.99 % | $ 661 M | ||
|
Becton, Dickinson and Company
BDX
|
1.97 B | $ 203.2 | 1.05 % | $ 58.5 B | ||
|
Repligen Corporation
RGEN
|
19.6 M | $ 150.44 | -3.8 % | $ 8.38 M | ||
|
ResMed
RMD
|
159 M | $ 256.15 | -0.57 % | $ 37.4 B | ||
|
STERIS plc
STE
|
281 M | $ 261.9 | 0.02 % | $ 25.8 B | ||
|
BioLife Solutions
BLFS
|
3.57 M | $ 21.91 | -2.97 % | $ 1.01 B | ||
|
Stereotaxis
STXS
|
3.19 M | $ 2.21 | -5.36 % | $ 178 M | ||
|
Retractable Technologies
RVP
|
4.29 M | $ 0.7 | -1.03 % | $ 21 M | ||
|
STAAR Surgical Company
STAA
|
16.7 M | $ 18.9 | -0.24 % | $ 928 M | ||
|
Utah Medical Products
UTMD
|
769 K | $ 61.21 | -0.71 % | $ 222 M | ||
|
Teleflex Incorporated
TFX
|
141 M | $ 104.44 | -0.96 % | $ 4.89 B | ||
|
West Pharmaceutical Services
WST
|
239 M | $ 231.57 | -0.4 % | $ 16.9 B | ||
|
DENTSPLY SIRONA
XRAY
|
241 M | $ 12.47 | 1.63 % | $ 2.53 B |